Improved survival with HPV among african americans with oropharyngeal cancer

Clinical Cancer Research

Volumn 19, Issue 9, 2013, Pages 2486-2492

  Worsham, Maria J ^a   Stephen, Josena K ^a   Chen, Kang Mei ^a   Mahan, Meredith ^a   Schweitzer, Vanessa ^a   Havard, Shaleta ^a   Divine, George ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CAUCASIAN; COHORT ANALYSIS; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OROPHARYNGEAL SQUAMOUS CELL CANCER; OROPHARYNX CANCER; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SEXUAL BEHAVIOR; SMOKING; VIRUS DETECTION; WART VIRUS;

AFRICAN AMERICANS; AGED; CARCINOMA, SQUAMOUS CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE;

EID: 84877098137     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3003     Document Type: Article

References (39)

1. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:951-62. (Pubitemid 28411496)
2. Shavers VL, Harlan LC, Winn D, Davis WW. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev 2003;22:25-38. (Pubitemid 36363511)
3. American Cancer Society. Cancer Facts & Figures 2011. Atlanta: American Cancer Society; 2011.
4. Murdock JM, Gluckman JL. African-American and white head and neck carcinoma patients in a university medical center setting. Are treatments provided and are outcomes similar or disparate? Cancer 2001;91:279-83.
5. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
6. Arbes SJ Jr, Olshan AF, Caplan DJ, Schoenbach VJ, Slade GD, Symons MJ. Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States). Cancer Causes Control 1999;10:513-23.
7. Goodwin WJ, Thomas GR, Parker DF, Joseph D, Levis S, Franzmann E, et al. Unequal burden of head and neck cancer in the United States. Head Neck 2008;30:358-71. (Pubitemid 351480753)
8. Gourin CG, Podolsky RH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope 2006;116:1093-106. (Pubitemid 44317932)
9. Settle K, Posner MR, Schumaker LM, Tan M, Suntharalingam M, Goloubeva O, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila Pa) 2009;2:776-81.
10. Chernock RD, Zhang Q, El-Mofty SK, Thorstad WL, Lewis JS Jr. Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. Arch Otolaryngol Head Neck Surg 2011;137:163-9.
11. Worsham MJ, Stephen JK, Lu M, Chen KM, Havard S, Shah V, et al. Disparate molecular, histopathology, and clinical factors in head and neck squamous cell carcinoma racial groups. Otolaryngol Head Neck Surg 2012;2:281-8.
12. Chen K, Sawhney R, Khan M, Benninger MS, Hou Z, Sethi S, et al. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2007;133:1131-8. (Pubitemid 350157026)
13. Stephen JK CK, Havard S, Lu M, Shah V, Schweitzer VP, Gardner G, Worsham MJ. HPV outcomes in an access to care laryngeal cancer cohort. Otolaryngol Head Neck Surg 2012;146:730-8.
14. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc 1995;57:289-300.
15. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007;99:777-89. (Pubitemid 47073524)
16. Gillison ML, Lowy DR. A causal role for human papillomavirus in head and neck cancer. Lancet 2004;363:1488-9.
17. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
18. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294-301.
19. Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol.11:781-9.
20. Schrank TP, Han Y, Weiss H, Resto VA. Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States - possible role for human papillomavirus in survival disparities. Head Neck.33:45-53.
21. Weinberger PM, Merkley MA, Khichi SS, Lee JR, Psyrri A, Jackson LL, et al. Human papillomavirus-active head and neck cancer and ethnic health disparities. Laryngoscope 2010;120:1531-7.
22. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009;199:1263-9.
23. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56. (Pubitemid 46740304)
24. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407-20. (Pubitemid 351480511)
25. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20. (Pubitemid 30365531)
26. http://www.cdc.gov/nchs/NSFG.htm. The 2002 National Survey of Family Growth.
27. Gates GJ, Sonenstein FL. Heterosexual genital sexual activity among adolescent males: 1988 and 1995. Fam Plann Perspect 2000;32:295-7.
28. Brawley OW. Oropharyngeal cancer, race, and the human papillomavirus. Cancer Prev Res (Phila) 2009;2:769-72.
29. Sikora AG, Morris LG, Sturgis EM. Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men. Arch Otolaryngol Head Neck Surg 2009;135:402-5.
30. Ang K, Zhang Q, Wheeler RH, Rosenthal DI, Nguyen-Tan F, Kim H, et al. A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): impact of radiation and cisplatin intensity on outcome. J Clin Oncol 28:15s, 2010 (suppl; abstr 5507).
31. Brockstein B, Haraf DJ, Rademaker AW, Kies MS, Stenson KM, Rosen F, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 2004;15:1179-86. (Pubitemid 39199304)
32. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev 2005;14:2287-93. (Pubitemid 41437826)
33. Onoda N, Nehmi A, Weiner D, Mujumdar S, Christen R, Los G. Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents. Head Neck 2001;23:860-70. (Pubitemid 32862290)
34. Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012;30:2102-11.
35. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006;31:259-66. (Pubitemid 44141088)
36. Lajer CB, von Buchwald C. The role of human papillomavirus in head and neck cancer. Apmis 2010;118:510-9.
37. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patientswith human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-9. (Pubitemid 351480538)
38. Mydlarz WK, Hennessey PT, Califano JA. Advances and Perspectives in the molecular diagnosis of head and neck cancer. Expert Opin Med Diagn 2010;4:53-65.
39. Worsham MJ SJ, Lu M, Chen KM, Havard S, Shah V, Schweitzer VG. Disparate molecular, histopathology, and clinical factors in HNSCC racial groups. Otolaryngol Head Neck Surg 2012;147:281-8.